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Case Report
Isolated Hepatic Splenosis" First Reported Case
MICHAEL D’ANGELICA, YUMAN FONG and LESLIE H. BLUMGART*
Hepatobiliary Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center
(Received 10 June 1997)
Splenosis is the autotransplantation of splenic
tissue, most commonly seen after traumatic splenic
rupture and splenectomy. Post-traumatic splenosis
is often considered a rare entity, but is probably
underreported because of its asymptomatic nature.
We describe the first reported case of splenosis
presenting as a liver mass, indistinguishable from a
liver tumor by standard preoperative evaluation.
The pathophysiology, evaluation and management
of splenosis is discussed as well as the decision to
resect a benign appearing liver mass.
Keywords: Splenosis, liver mass, liver resection
been shown, both experimentally and clinically,
to be able to implant anywhere they are spread
at the time of trauma [1]. We present the first
reported case of splenosis presenting as an iso-
lated liver mass, indistinguishable from a liver
tumor by standard preoperative evaluation. The
clinical presentation of this entity will be
reviewed and the importance of a high index
of suspicion for this diagnosis in patients with a
history of splenic trauma emphasized.
INTRODUCTION
Splenosis, the autotransplantation of splenic
tissue, is a well documented phenomena after
splenic rupture and splenectomy. Nodules are
characteristically multiple, diffusely spread
throughout the peritoneal cavity and appear as
small reddish blue nodules. Post traumatic
splenosis is generally considered an uncommon
event, but is probably under reported because of
its asymptomatic nature. Splenic implants have
CASE REPORT
The patient is a 38 year old female with a history
of alcohol use and intermittent oral contra-
ceptive use who was found to have abnormal
liver enzymes on a screening test performed by
her primary care physician. She had no history
of weight loss, abdominal pain or jaundice. Her
past medical history was significant for a distal
pancreatectomy and splenectomy after a motor
vehicle accident 20 years prior to admission. She
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denied any history of smoking and reported
drinking six cans of beer a day. There was no
significant family history of malignancy.
Physical examination revealed a well devel-
oped, healthy appearing middle aged female
with normal vital signs. Sclera were anicteric.
Abdominal exam revealed a long left-parame-
dian scar, a transverse left upper quadrant scar
and a right lower quadrant scar with no
palpable masses or hepatosplenomegaly. There
was no abdominal tenderness or evidence of
ascites. The remainder of the exam was within
normal limits.
Serum chemistries were significant for glucose
of 147 mg/dl (65-115), alkaline phosphatase of
231 U/L (25-140), AST of 288 U/L (0-40), ALT
of 161 U/L (0-45), total bilirubin of 1.4 mg/dl
(0.1-1.2), and a GGTP of 2490 U/L (0-85).
Serologies for Hepatitis A, B and C were negative.
An abdominal ultrasound was performed that
revealed diffusely increased echogenicity in the
liver consistent with hepatocellular disease, and
a hypoechoic lesion felt to be in the left liver
measuring 3.6 x 3.9cm. Absence of the spleen
was confirmed. ACT scan of the abdomen was
then obtained (Fig. 1) and showed hepatomegaly
with diffusely decreased density throughout
the liver consistent with fatty infiltration. A
rounded, well circumscribed high density mass
was seen in the anterior aspect of the liver
straddling the medial and lateral segments of
the left liver, measuring 3.2x3.6 cm. No central
scar in the mass was appreciated. The etiology of
the mass was felt to be focal nodular hyperplasia
or an adenoma.
The patient desired surgical removal of this
mass because of associated bleeding risks and
was referred to us. She was taken to the
operating room where extensive adhesions from
her previous trauma were noted. There were
also dense adhesions between the liver in the
area of the tumor and the undersurface of the
diaphragm. The tumor was found to be approxi-
mately 2.5 cm in diameter, located within the
umbilical fissure and to be approximately 2.5 cm
in diameter, located within the umbilical fissure
and occupying part of segments 3 and 4. Th rest
of the abdominal exploration was unremarkable.
The tumor was subsequently enucleated and the
operative diagnosis by gross inspection (Fig. 2)
was an adenoma. The patients post operative
recovery was uneventful. Histologic examina-
FIGURE Abdominal computed tomography scan revealing a 3.2x3.6 cm high density mass in the anterior aspect of the left
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FIGURE 2 Gross pathological specimen indistinguishable from a hepatic adenoma.
tion of the mass revealed splenic tissue attached
to the liver surface with unremarkable liver and
splenic parenchyma.
DISCUSSION
Splenosis is caused by the implantation of
splenic fragments onto exposed vascularized
surfaces at the time of splenic trauma. The blood
supply to these splenic implants is derived from
small penetrating vessels arising from donor
surfaces. The implants are usually small and
multiple with as many as hundreds throughout
the peritoneal cavity. The fragments can implant
anywhere to which they have access, but are
most commonly found on the serosal surfaces of
the small intestine, greater omentum, mesentery,
undersurface of the diaphragm and in the pelvis
[1]. There have been reports of thoracic splenosis
following diaphragmatic rupture and subcuta-
neous splenosis following gunshot wounds
through the spleen [1,2]. Splenic implants
mimicking renal masses [3] and intestinal
masses [1] have also been reported. There have
been two previous reports of splenic implants on
the surface of the liver, however they were
incidental findings at autopsy [4]. Presumably,
for a splenic nodule to implant in the liver, there
must be a simultaneous rupture of the liver
capsule at the time of trauma. This case
represents the first report of an antemortem
diagnosis of hepatic splenosis and emphasizes
the need to consider this diagnosis in a patient
with a history of splenic trauma.
We report a patient who presented with
abnormal liver enzymes and a hepatic mass that
was clinically consistent with a adenoma or focal
nodular hyperplasia. Operatively, the mass was
felt to be an adenoma. The patient also had a
significant histroy of alcohol use and this may
have been the cause of her laboratory abnorm-
alities, Since hepatic adenomas have a signifi-
cant risk of hemorrhage and are potentially
premalignant, a resection was performed. This
case emphasizes the need to consider splenosis
in the differential diagnosis of an unexplained
hepatic mass in patients who have a history of
splenic trauma. Although, this is the first report
of a splenic nodule presenting as an isolated
hepatic mass, if splenosis was considered pre-42 M. D’ANGELICA et al.
operatively, the patient may have been spared a
laparotomy and resection.
Splenosis was once thought to be uncommon,
but the incidence of splenosis following trauma
or surgery is probably underreported because
the large majority of cases are asymptomatic.
Recently it has been reported in 26 to 67% of
patients with traumatic rupture of the spleen [3].
The most common presentation of splenosis is
an incidental finding at laparotomy or laparo-
scopy for unrelated disease. Rarely, splenosis
will become symptomatic as a cause of bowel
obstruction or abdominal pain, but there are
usually associated confounding factors in these
cases [1].
The entities most often confused with spleno-
sis at laparotomy are metastatic cancer, endo-
metriosis, hemangiomas and accessory spleens.
Differentiating these diagnoses can be difficult.
It is important to understand the difference
between splenosis and accessory spleens. In
contrast to splenosis, accessory spleens are
congenital, usually limited in number (rarely
more than six), are typically located along the
splenopancreatic ligament, are supplied by a
branch of the splenic artery and have a true hilus
[4]. Although, the splenic implant in this case
was singular, it lacked a hilus, followed splenic
trauma and was anatomically inconsistent with
an accessory spleen. We are therefore convinced
that this is a case of splenosis.
The immunologic value of the spleen is well
documented and it is known that susceptibility
to overwhelming infection is much higher in the
asplenic host. Interestingly, it has been shown
that splenic nodules left behind after splenec-
tomy retain splenic filtering and immunologic
function [5]. Given its innocuous nature, sple-
nosis may be beneficial after traumatic splenic
splenic rupture. Indeed, there is no indication to
remove splenosis if the patient is asymptomatic.
Because most remnant splenic tissue is
asymptomatic and may be beneficial to the host,
preoperative diagnosis is desirable. However,
splenosis is rarely encountered by the physician
and not often thought of. The most important
principle is to have a high level of suspicion in
patients with unexplained masses and a history
of splenic trauma. Typical imaging modalities
used for abdominal masses scuh as CT or
ultrasound will not differentiate splenosis from
other entities. Scintigraphy with heat damaged
red blood cells is the best test to obtain if the
diagnosis is considered [2]. Indeed if an un-
explained mass is proven to be splenic tissue
and the patient lacks any symptoms from it,
splenosis should not be resected. This report
widens the spectrum of presentation for sple-
nosis and adds the liver as a potential site of its
presentation.
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